Related references
Note: Only part of the references are listed.Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning
Jessica L. Bridgford et al.
BLOOD (2020)
MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491
Gabriel Levy et al.
BLOOD (2020)
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations
Stephan Wilmes et al.
SCIENCE (2020)
Orchestration of signaling by structural disorder in class 1 cytokine receptors
Pernille Seiffert et al.
CELL COMMUNICATION AND SIGNALING (2020)
Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
Claire Gorby et al.
SCIENCE SIGNALING (2020)
IMMUNOTHERAPY Engineering cytokines and cytokine circuits
Aileen W. Li et al.
SCIENCE (2020)
Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia
Naomi Cornish et al.
BLOOD ADVANCES (2020)
The regulation of JAKs in cytokine signaling and its breakdown in disease
Henrik M. Hammaren et al.
CYTOKINE (2019)
Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutations
Henrik M. Hammaren et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Differential effect of inhibitory strategies of the V617 mutant of JAK2 on cytokine receptor signaling
Emilie Leroy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
Kritika Mohan et al.
SCIENCE (2019)
Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim
Hanny Al-Samkari et al.
ANNALS OF HEMATOLOGY (2019)
Hepatic thrombopoietin is required for bone marrow hematopoietic stem cell maintenance
Matthew Decker et al.
SCIENCE (2018)
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene
Patrizia Noris et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
Alessandro Pecci et al.
EMBO MOLECULAR MEDICINE (2018)
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2017)
Identification of MPL R102p Mutation in Hereditary thrombocytosis
Christine Bellanne-Chantelot et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
Isabelle Plo et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in thrombopoietin
Aaron Seo et al.
BLOOD (2017)
A novel germ-line mutation of c-mpl gene in a sporadic case of essential thrombocythemia
Anna Maria Lombardi et al.
BLOOD CELLS MOLECULES AND DISEASES (2017)
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
Jelena D. Milosevic Feenstra et al.
BLOOD (2016)
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
Xenia Cabagnols et al.
BLOOD (2016)
His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor
Emilie Leroy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Live-cell single-molecule imaging of the cytokine receptor MPL for analysis of dynamic dimerization
Akihiko Sakamoto et al.
Journal of Molecular Cell Biology (2016)
IBS: an illustrator for the presentation and visualization of biological sequences
Wenzhong Liu et al.
BIOINFORMATICS (2015)
The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling
Renata Grozovsky et al.
NATURE MEDICINE (2015)
Thrombopoietin from beginning to end
Ian S. Hitchcock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling
Veena Sangkhae et al.
EXPERIMENTAL HEMATOLOGY (2014)
Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation
Ashley P. Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Andrew J. Brooks et al.
SCIENCE (2014)
Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia
Majed J. Dasouki et al.
BLOOD (2013)
Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure
Yu Seiki et al.
HAEMATOLOGICA (2013)
Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation
Jean-Philippe Defour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia
Michele P. Lambert et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation
Bethan Psaila et al.
BLOOD (2012)
Presenting your structures: the CCP4mg molecular-graphics software
S. McNicholas et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
A novel splice donor mutation in the thrombopoietin gene leads to exon 2 skipping in a Filipino family with hereditary thrombocythemia
Dana Ng et al.
BLOOD (2011)
Orientation-specific signalling by thrombopoietin receptor dimers
Judith Staerk et al.
EMBO JOURNAL (2011)
Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation
Erin E. Matthews et al.
FASEB JOURNAL (2011)
Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC)
Wei-Min Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Compound heterozygous c-Mpl mutations in a child with congenital amegakaryocytic thrombocytopenia: Functional characterization and a review of the literature
Norma E. Fox et al.
EXPERIMENTAL HEMATOLOGY (2009)
MPL mutations in myeloproliferative disorders:: analysis of the PT-1 cohort
Philip A. Beer et al.
BLOOD (2008)
Activating mutations in human acute megakaryoblastic leukemia
Sebastien Malinge et al.
BLOOD (2008)
YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation
Ian S. Hitchcock et al.
BLOOD (2008)
Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia
Marloes R. Tijssen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family
Kun Liu et al.
HAEMATOLOGICA (2008)
Dual role of Mpl receptor during the establishment of definitive hematopoiesis
Laurence Petit-Cocault et al.
DEVELOPMENT (2007)
NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains
Min-Ju Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The membrane-proximal region of the thrombopoietin receptor confers its high surface expression by JAK2-dependent and -independent mechanisms
Wei Tong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Thrombopoietin contributes to enhanced platelet activation in patients with unstable angina
Enrico Lupia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis
Takanori Nakamura et al.
BLOOD (2006)
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer
RJ Brown et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment
MD Feese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
F Ding et al.
BLOOD (2004)
The glycan domain of thrombopoietin (TPO) acts in trans to enhance secretion of the hormone and other cytokines
HM Linden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo)
D Bouscary et al.
ONCOGENE (2001)
c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia
M Ballmaier et al.
BLOOD (2001)
Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia
S van den Oudenrijn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
The glycan domain of thrombopoietin enhances its secretion
HM Linden et al.
BIOCHEMISTRY (2000)
Share Paper
